Brokers' take

Manulife US Reit | Buy Feb 14 close: US$0.86 Target price: US$0.96 RHB Research, Feb 14

Manulife US Reit reported a strong set of maiden FY16 results with distribution per unit exceeding its initial public offering forecasts by 5 per cent. Among S-Reits, Manulife US Reit offers the best proxy to the strengthening US economy via its three quality freehold office properties. The US office market is gaining traction with strong jobs data and the new president's pro-business policy stance likely to provide further impetus. With the Reit offering superior FY17 forecast yields of 7.3 per cent, above S-Reits' average of 6.4 per cent, we believe there is room for further yield compression. Maintain "buy" and a target price of US$0.96 (12 per cent upside).

Singapore Post | Hold Target price: S$1.42 Feb 14 close: S$1.375 OCBC Investment Research, Feb 14